Congressman Greg Murphy, M.D., is recognizing May as Bladder Cancer Awareness Month. “While most bladder cancers are caught ...

Bladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...

Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment ...

ImmunityBio's ANKTIVA sBLA for papillary bladder cancer was rejected by the FDA despite prior support, prompting the company ...

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk ...

What Is Muscle Invasive Bladder Cancer? About 70% of people diagnosed with bladder cancer have what is called non-muscle invasive cancer, or superficial bladder cancer. The cancer cells remain in ...

A 50-year-old resident of Cheshire, who mistook his initial symptoms of bladder cancer to be a UTI, drank cranberry juice as ...

Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

Bladder cancer patients undergoing radical cystectomy after pelvic radiotherapy showed increased risks of rectal injury, ...

Though the connection seems unusual, this news could change the lives of more than 700,000 Americans living with this disease ...

CG Oncology, Inc. (NASDAQ:CGON) announced on Saturday that cretostimogene grenadenorepvec monotherapy data were presented at ...

The targeted drug release device TAR-200 shows promising response and disease-free survival rates in specific populations of ...